Biologics

Precision Spine, HippoFi enters partnership to boost biologics sales

Precision Spine and HippoFi inked an agreement to help drive the sales of Pur Biologics products.

By: Carly Behm

Wednesday, October 5th, 2022

The deal will allow HippoFi to sell Pur Biologics products alongside Precision Spine’s implant portfolio, HippoFi said in an Oct. 5 news release. Pur Biologics is a division of HippoFi.

The partnership is expected to speed up the commercialization of the regenerative products through Precision Spine’s brand recognition.

Next Up in Biologics

6 ways biologics is advancing in spine

So far this year, medtech companies and academic institutions are making key strides in spine biologics. From new product launches…

By: Carly Behm
Thursday, February 19th, 2026
Medtronic spinal bone graft earns expanded FDA approval

Medtronic’s Infuse bone graft earned the FDA’s premarket approval for one- and two-level transforaminal lumbar interbody spinal fusions. The expanded…

By: Carly Behm
Tuesday, February 17th, 2026
Vivex spine bone graft sees strong long-term outcomes: Study

Vivex Biologics’ VIA Form+ cryopreserved viable bone allograft saw 100% radiograhpic fusion success within six months of surgery, according to…

By: Carly Behm
Thursday, February 12th, 2026

Comments are closed.

Scaling AI with confidence: Turning early use cases into enterprise value

Next Up in Biologics

6 ways biologics is advancing in spine

Medtronic spinal bone graft earns expanded FDA approval

Vivex spine bone graft sees strong long-term outcomes: Study

Join the spine leaders & surgeons who start their day with Becker's